Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stock Market LIVE: Sensex up 300 pts, Nifty above 23,850; IT, pharma & healthcare stocks lead
Sensex Today | Stock Market LIVE Updates Wednesday: In the broader markets, the Nifty MidCap and the Nifty SmallCap were trading 0.04 per cent and 0.12 per cent lower, respectively
Stock Market News Today Live Updates: Nifty Slips Below 24,050 Amid F&O Expiry, Sensex Falls Over 150 Points; Vedanta Slides 5% After Block Deals
Nifty IT and Nifty Metal fell 1.22% each, leading losses among sectoral indices. Nifty Pharma rose 0.90%, while Nifty Media gained 0.52% and Nifty India Defence advanced 0.33%.
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGC
Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despite this, the broader recovery trend remains intact above 23,700. Several companies like Sun Pharma, Tata Motors, and ONGC are in focus due to significant business developments, including acquisitions, order wins, and strategic repositioning.
NHB probing Aavas Financiers over loan classification lapses
The sector regulator has recalled refinancing support worth nearly Rs 500 crore —a punitive action that has set off a sweeping leadership overhaul at the company. ET was the first to report on April 13 that managing director and CEO Sachinder Bhinder was being asked to step down, with Manu Singh — former home loans head at Kotak Mahindra Bank — set to take over. A week later, on April 20, the company confirmed Bhinder's resignation and Singh's appointment as the new CEO.
NHB probing Aavas Financiers over loan classification lapses
The sector regulator has recalled refinancing support worth nearly Rs 500 crore —a punitive action that has set off a sweeping leadership overhaul at the company. ET was the first to report on April 13 that managing director and CEO Sachinder Bhinder was being asked to step down, with Manu Singh — former home loans head at Kotak Mahindra Bank — set to take over. A week later, on April 20, the company confirmed Bhinder's resignation and Singh's appointment as the new CEO.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Small-caps, PSUs and pharma remain Gautam Shah's top market themes for 2026
Gautam Shah, Founder of Goldilocks Global Research, sees the Nifty remaining range-bound between 23,150 and 24,000, while forecasting the small-cap index could rise to 20,000. Shah also believes Indian IT stocks are nearing a bottom and that PSU stocks could deliver 25-30% returns over the next 12-18 months.